Effect of an immunotoxin to folate receptor on bleomycin-induced experimental pulmonary fibrosis

Clinical and Experimental Immunology

Volumn 161, Issue 2, 2010, Pages 348-356

  Nagai, T ^a   Tanaka, M ^a   Hasui, K ^a   Shirahama, H ^b   Kitajima, S ^a   Yonezawa, S ^a   Xu, B ^c   Matsuyama, T ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Department of Pathology   (Japan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

folate receptor; immunotoxin; macrophages; pulmonary fibrosis

Indexed keywords

BLEOMYCIN; CYTOKINE; FOLATE RECEPTOR; FOLATE RECEPTOR BETA; HYDROXYPROLINE; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOTOXIN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; PSEUDOMONAS EXOTOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BACTERIAL TOXINS; BLEOMYCIN; CARRIER PROTEINS; CHEMOKINE CCL2; EXOTOXINS; HUMANS; HYDROXYPROLINE; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTOXINS; LUNG; MACROPHAGES; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MONOCYTE CHEMOATTRACTANT PROTEINS; PULMONARY FIBROSIS; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE FACTORS;

EID: 77954636757     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04182.x     Document Type: Article

References (42)

1. Thomeer MJ, Vansteenkiste J, Verbeken EK, Demedts M. Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respir Med 2004 98 : 567 73.
2. Noble PW. Idiopathic pulmonary fibrosis: natural history and prognosis. Clin Chest Med 2006 27 : S11 16.
3. Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2009 2 : 103 21.
4. White ES, Lazar MH, Thannickal VJ. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 2003 201 : 343 54.
5. Homolka J, Ziegenhagen MW, Gaede KI, Entzian P, Zissel G, Müller-Quernheim J. Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis. J Respir 2003 70 : 262 9.
6. Kadota J, Mizunoe S, Mito K et al. High plasma concentrations of osteopontin in patients with interstitial pneumonia. Respir Med 2005 99 : 111 17.
7. Ide M, Ishii H, Mukae H et al. High serum levels of thrombospondin-1 in patients with idiopathic interstitial pneumonia. Respir Med 2008 102 : 1625 30.
8. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008 294 : L152 60.
9. Okuma T, Terasaki Y, Kaikita K et al. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. J Pathol 2004 204 : 594 604.
10. Moore BB, Murray L, Das A, Wilke CA, Herrygers AB, Toews GB. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006 35 : 175 81.
11. Ishida Y, Kimura A, Kondo T et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am J Pathol 2007 170 : 843 54.
12. Baran CP, Opalek JM, McMaken S et al. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2007 176 : 78 89.
13. Piguet PF, Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 1994 7 : 515 18.
14. Tanino Y, Makita H, Miyamoto K et al. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002 283 : L156 62.
15. Inoshima I, Kuwano K, Hamada N et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2004 286 : L1038 44.
16. Elnakat H, Ratnam M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev 2004 56 : 1067 84.
17. Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008 41 : 120 9.
18. Nagayoshi R, Nagai T, Matsushita K et al. Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages. Arthritis Rheum 2005 52 : 2666 75.
19. Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng JX, Low PS. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 2009 113 : 438 46.
20. Nagai T, Tanaka M, Tsuneyoshi Y et al. In vitro and in vivo efficacy of a recombinant immunotoxin against folate receptor beta on the activation and proliferationof rheumatoid arthritis synovial cells. Arthritis Rheum 2006 54 : 3126 34.
21. American Thoracic Society and the European Respiratory Society (ERS). Idiopathic pulmonary fibrosis: diagnosis and treatment:international consensus statement. Am J Respir Crit Care Med 2000 161 : 646 64.
22. Nagai T, Tanaka M, Tsuneyoshi Y et al. Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta. Cancer Immunol Immunother 2009 58 : 1577 86.
23. Gharaee-Kermani M, Ullenbruch M, Phan SH. Animal models of pulmonary fibrosis. Methods Mol Med 2005 117 : 251 9.
24. Ashcroft T, Simpson JM, Timbrell VJ. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. Clin Pathol 1988 41 : 467 70.
25. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996 29 : 225 9.
26. Higashiyama H, Yoshimoto D, Okamoto Y, Kikkawa H, Asano S, Kinoshita M. Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis. J Clin Pathol 2007 60 : 283 9.
27. Smith RE, Strieter RM, Phan SH, Lukacs N, Kunkel SL. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol 1998 64 : 528 36.
28. McMillan TR, Moore BB, Weinberg JB et al. Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am J Respir Crit Care Med 2008 177 : 771 80.
29. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008 214 : 199 210.
30. Lloyd CM, Minto AW, Dorf ME et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997 185 : 1371 80.
31. Moore BB, Kolodsick JE, Thannickal VJ et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005 166 : 675 84.
32. Ishida Y, Kimura A, Kondo T et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am J Pathol 2007 170 : 843 54.
33. Belperio JA, Dy M, Burdick MD et al. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2002 27 : 419 27.
34. Ma B, Zhu Z, Homer RJ, Gerard C, Strieter R, Elias JA. The C10/CCL6 chemokine and CCR1 play critical roles in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2004 172 : 1872 81.
35. Piguet PF, Rosen H, Vesin C, Grau GE. Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Respir Dis 1993 147 : 435 41.
36. Zeni F, Parent C, Correa R et al. ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumonia. J Appl Physiol 1999 87 : 299 307.
37. De Lorenzo C, D'Alessio G. From immunotoxins to immunoRNases. Pharm Biotechnol 2008 9 : 210 14.
38. Jackman AL, Theti DS, Gibbs DD. Antifolates targeted specifically to the folate receptor. Adv Drug Deliv Rev 2004 56 : 1111 25.
39. van der Heijden JW, Oerlemans R, Dijkmans BA et al. Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum 2009 60 : 12 21.
40. Parra ER, Kairalla RA, Ribeiro de Carvalho CR, Eher E, Capelozzi VL. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration 2007 74 : 159 69.
41. Matteson EL, Lowe VJ, Prendergast FG et al. Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical FolatescanTM. Clin Exp Rheumatol 2009 27 : 253 9.
42. Maher TM, Wells AU, Laurent GJ. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J 2007 30 : 835 9.